XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED CASH FLOW STATEMENTS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Apr. 01, 2012
Cash flows from operating activities:    
Net income $ 22,245 $ 24,275
Adjustments to reconcile net income to net cash provided by (used for) operating activities:    
Depreciation and amortization 22,546 12,157
Share-based compensation 3,419 2,977
Provision for inventory obsolescence 474 2,491
Pension funding less than pension expense 798 756
Income from equity method investment (2,271) (2,741)
Tax benefit related to share-based compensation (4,227) (4,119)
Changes in operating assets and liabilities, net of the effects of currency exchange rate changes and acquired businesses:    
Receivables (9,785) 11,904
Inventories (2,723) (4)
Accounts payable 5,520 (5,634)
Accrued liabilities (30,347) (30,141)
Accrued taxes (69,987) 5,105
Other assets (5,606) (215)
Other liabilities (1,782) (4,063)
Net cash provided by (used for) operating activities (71,726) 12,748
Cash flows from investing activities:    
Cash used to acquire businesses, net of cash acquired (9,475) (587)
Capital expenditures (6,437) (7,557)
Proceeds from disposal of businesses 3,735  
Proceeds from disposal of tangible assets 1,077  
Net cash used for investing activities (11,100) (8,144)
Cash flows from financing activities:    
Borrowings under credit arrangements 388,220  
Payments under borrowing arrangements (194,110) (600)
Payments under share repurchase program (31,250) (25,000)
Debt issuance costs paid (6,794)  
Cash dividends paid (76) (2,409)
Proceeds from exercise of stock options, net of withholding tax 1,551 2,179
Tax benefit related to share-based compensation 4,227 4,119
Net cash provided by (used for) financing activities 161,768 (21,711)
Effect of foreign currency exchange rate changes on cash and cash equivalents (4,631) 4,408
Increase (decrease) in cash and cash equivalents 74,311 (12,699)
Cash and cash equivalents, beginning of period 395,095 382,716
Cash and cash equivalents, end of period $ 469,406 $ 370,017